MDXG today
$3.32-$0.05 (-1.48%)close Nov 11, 2026Trend
DailyUptrend (starting)
4 hourStrong Bearish
1 hourLeaning Bearish
15 minBearish
5 minStrong Bearish
Daily trend turns down below $3.00
Key levels
Resistance$4.34
Resistance$3.38
Support$3.00
Latest news & SEC filings
DealMIMEDX signs patent license deal with wound care competitor
EarningsMIMEDX posts Q3 2026 results
EarningsMiMedx Group holds Q3 2026 earnings call
All MDXG news →About MiMedx
MiMedx develops and sells tissue-based products for wound care and surgical applications. Its main offerings include placental allografts such as EPIFIX, EPICORD, and EPIEFFECT, along with xenograft and collagen-based products. Customers include physicians, wound care centers, hospitals, and government facilities, primarily in the United States, with expansion into Japan.
Based on the company's 10-K filed Feb 25, 2026.
Nasdaq · Healthcare
MIMEDX GROUP, INC. (MDXG)
What Is the Price Target for MDXG?
SEPT Low Target
$7.00
SEPT Mid Target
$7.50
SEPT High Target
$8.00
Analyst Consensus
$7.50
Is MDXG a Buy or Sell Right Now?
Thesis
- •Revenue growing 20.0% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for MDXG.
Start Free Trial →Is MDXG Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$6.55
43
Moat Score
NARROW
5/9
Piotroski Score
5.8
Altman Z-Score
What Is Smart Money Doing with MDXG?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| BIERMAN JAMES L | director | Buy | 50,913 | $185K | Jun 10, 2026 |
| PUHY DOROTHY E | director | Buy | 50,913 | $185K | Jun 10, 2026 |
| Newton Todd | director | Buy | 50,913 | $185K | Jun 10, 2026 |
| HAWKINS WILLIAM A | director | Buy | 50,913 | $185K | Jun 10, 2026 |
| Olson Tiffany | director | Buy | 50,913 | $185K | Jun 10, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →MDXG Growth Story
Revenue YoY
20.0%
3yr Revenue CAGR
16.1%
EPS Growth YoY
14.29%
FCF Growth YoY
N/A%
Revenue Trend
STRONG
Dark Pool Trades for MDXG
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for MDXG, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:26:56 | $3.32 | 5,334 | $$18K | BUY |
| 21:01:35 | $3.32 | 1,657 | $$6K | BUY |
| 21:01:25 | $3.32 | 1,815 | $$6K | BUY |
| 21:01:24 | $3.32 | 3,920 | $$13K | BUY |
| 21:00:08 | $3.32 | 3,186 | $$11K | SELL |
5 dark pool trades shown · $$53K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for MIMEDX GROUP, INC. (MDXG) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (7 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →MDXG — frequently asked questions
What is MDXG stock price today?
MIMEDX GROUP, INC. (MDXG) is at $3.32, down 1.48% (-$0.05) at the Nov 11, 2026 close.
Why is MDXG stock moving today?
Latest MDXG news — Oct 28, 2026: MIMEDX signs patent license deal with wound care competitor · Oct 28, 2026: MIMEDX posts Q3 2026 results
What is the MDXG price target?
The average analyst price target for MDXG is $7.50, ranging from $7 to $8, based on 2 analysts.
What do analysts rate MDXG?
Analyst ratings for MDXG: 0 Buy, 4 Hold, 0 Sell — consensus Hold.
Did MDXG beat earnings?
MDXG last reported on Oct 28, 2026: EPS -$0.01 vs $0.00 expected — a miss of 3433.3%.
Does MDXG pay a dividend?
MDXG does not currently pay a dividend.
What are MDXG support and resistance levels?
Support: $3.00. Resistance: $3.38, $4.34, $5.05.
What are insiders doing with MDXG?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on MDXG?
Oct 28, 2026: MIMEDX signs patent license deal with wound care competitor · Oct 28, 2026: MIMEDX posts Q3 2026 results · Oct 28, 2026: MiMedx Group holds Q3 2026 earnings call